1. Home
  2. NGVT vs EVO Comparison

NGVT vs EVO Comparison

Compare NGVT & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NGVT
  • EVO
  • Stock Information
  • Founded
  • NGVT 1964
  • EVO 1993
  • Country
  • NGVT United States
  • EVO Germany
  • Employees
  • NGVT N/A
  • EVO N/A
  • Industry
  • NGVT Major Chemicals
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • NGVT Industrials
  • EVO Health Care
  • Exchange
  • NGVT Nasdaq
  • EVO Nasdaq
  • Market Cap
  • NGVT 1.6B
  • EVO 1.6B
  • IPO Year
  • NGVT N/A
  • EVO 2021
  • Fundamental
  • Price
  • NGVT $31.39
  • EVO $3.03
  • Analyst Decision
  • NGVT Buy
  • EVO Buy
  • Analyst Count
  • NGVT 5
  • EVO 2
  • Target Price
  • NGVT $54.60
  • EVO $5.90
  • AVG Volume (30 Days)
  • NGVT 259.2K
  • EVO 103.7K
  • Earning Date
  • NGVT 04-30-2025
  • EVO 05-21-2025
  • Dividend Yield
  • NGVT N/A
  • EVO N/A
  • EPS Growth
  • NGVT N/A
  • EVO N/A
  • EPS
  • NGVT N/A
  • EVO N/A
  • Revenue
  • NGVT $1,406,400,000.00
  • EVO $866,665,179.00
  • Revenue This Year
  • NGVT N/A
  • EVO $3.70
  • Revenue Next Year
  • NGVT $4.80
  • EVO $10.32
  • P/E Ratio
  • NGVT N/A
  • EVO N/A
  • Revenue Growth
  • NGVT N/A
  • EVO N/A
  • 52 Week Low
  • NGVT $30.90
  • EVO $2.85
  • 52 Week High
  • NGVT $56.30
  • EVO $7.98
  • Technical
  • Relative Strength Index (RSI)
  • NGVT 22.35
  • EVO 24.48
  • Support Level
  • NGVT $37.77
  • EVO $3.16
  • Resistance Level
  • NGVT $39.63
  • EVO $3.31
  • Average True Range (ATR)
  • NGVT 1.56
  • EVO 0.09
  • MACD
  • NGVT -0.99
  • EVO -0.01
  • Stochastic Oscillator
  • NGVT 0.00
  • EVO 1.59

About NGVT Ingevity Corporation

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: